Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 10 » Issue 1

Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease

Authors Miravitlles M, Huerta A, Valle M, García-Sidro P, Forne C, Crespo C, Lopez-Campos JL

Received 25 October 2014

Accepted for publication 9 December 2014

Published 16 February 2015 Volume 2015:10(1) Pages 367—377


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Richard Russell

Marc Miravitlles,1,2 Alicia Huerta,3 Manuel Valle,4 Patricia García-Sidro,5 Carles Forné,6 Carlos Crespo,6,7 José Luis López-Campos2,8

1Pneumology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain; 2CIBER de Enfermedades Respiratorias (CIBERES); 3Market Access Department, GlaxoSmithKline, Tres Cantos, Madrid, Spain; 4Pneumology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain; 5Pneumology Department, Hospital Universitario de la Plana, Vila-real, Castellón, Spain; 6Health Economics and Outcome Strategies Department, Oblikue Consulting, Barcelona, Spain; 7Statistics Department, University of Barcelona, Barcelona, Spain; 8Unidad Médico Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Sevilla, Spain

Purpose: Health utilities are widely used in health economics as a measurement of an individual’s preference and show the value placed on different health states over a specific period. Thus, health utilities are used as a measure of the benefits of health interventions in terms of quality-adjusted life years. This study aimed to determine the demographic and clinical variables significantly associated with health utilities for chronic obstructive pulmonary disease (COPD) patients.
Patients and methods: This was a multicenter, observational, cross-sectional study conducted between October 2012 and April 2013. Patients were aged ≥40 years, with spirometrically confirmed COPD. Utility values were derived from the preference-based generic questionnaire EQ-5D-3L applying weighted Spanish societal preferences. Demographic and clinical variables associated with utilities were assessed by univariate and multivariate linear regression models.
Results: Three hundred and forty-six patients were included, of whom 85.5% were male. The mean age was 67.9 (standard deviation [SD] =9.7) years and the mean forced expiratory volume in 1 second (%) was 46.2% (SD =15.5%); 80.3% were former smokers, and the mean smoking history was 54.2 (SD =33.2) pack-years. Median utilities (interquartile range) were 0.81 (0.26) with a mean value of 0.73 (SD =0.29); 22% of patients had a utility value of 1 (ceiling effect) and 3.2% had a utility value lower than 0. The factors associated with utilities in the multivariate analysis were sex (beta =-0.084, 95% confidence interval [CI]: -0.154; -0.013 for females), number of exacerbations the previous year (-0.027, 95% CI: -0.044; -0.010), and modified Medical Research Council Dyspnea Scale (mMRC) score (-0.123 [95% CI: -0.185; -0.061], -0.231 [95% CI: -0.301; -0.161], and -0.559 [95% CI: -0.660; -0.458] for mMRC scores 2, 3, and 4 versus 1), all P<0.05.
Conclusion: Multivariate analysis showed that female sex, frequent exacerbations, and an increased level of dyspnea were the main factors associated with reduced utility values in patients with COPD.

Keywords: COPD, health utility, health-related quality of life, multivariate linear regression

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]